With the initials IBD, from English Inflammatory bowel diseasewe refer to the category of chronic inflammatory bowel diseaseranging from Crohn’s disease to ulcerative colitis. As the site recalls Humanitas, the global prevalence of IBD has increased by 85% over the past 30 years, with a number of sick people of around 7 million worldwide. That is why the result of the is of great interest new study Published on Gut and conducted by researchers at NYU Grossman School of Medicine.
What the new study says about the relationship between antibiotics and intestinal diseases
The research team has shown that exposure to antibiotics is associated with an increased and cumulative risk of inflammatory bowel disease, particularly among individuals aged 40 and over. The researchers looked at the dose-response relationship between antibiotic exposure and the development of IBD, the risk of Crohn’s disease and ulcerative colitis (UC), and the impact of antibiotic timing and different classes of antibiotics on the development of IBD. To do this, they used a large sample of 6,104,245 people.
The highest risk for developing inflammatory bowel disease was 1 to 2 years after taking antibiotics. To be particularly dangerous, in this sense, were found to be the nitroimidazole-based antibiotics And fluoroquinolones, usually prescribed to treat intestinal infections. In reverse nitrofurantoin is the only antibiotic class not associated with the risk of intestinal inflammationregardless of age.
The reasons why there is (still) a serious shortage of medicines in Italy
Bone health in a glass of water
Source: Vanity Fair
I’m Susan Karen, a professional writer and editor at World Stock Market. I specialize in Entertainment news, writing stories that keep readers informed on all the latest developments in the industry. With over five years of experience in creating engaging content and copywriting for various media outlets, I have grown to become an invaluable asset to any team.
